Detalles de la búsqueda
1.
A randomized controlled, open-label early phase II trial comparing incidence of FOLFIRI.3-induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer.
J Clin Pharm Ther;
44(6): 946-951, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31407827
Resultados
1 -
1
de 1
1
Próxima >
>>